Thursday, March 24, 2022

Ipca Laboratories Walk In 27th March 2022 for Bsc,B.Pharm, D.Pharm,10th ,12th, ITI

 Ipca Laboratories Limited Walk In Interview 2022   B. Sc., B.Pharm, D. Pharm, 10th , 12th, ITI (LACP, Instrumentation, AOCP ) for Officer / Sr. Officer / Assistant/ Technician/ Trainee  At  Athal, Silvassa, D&NH&DD  . Ipca Laboratories Limited Notification full detailes below.Interested and eligible candidates can attend interview on scheduled time and venue.

  • Vacancy details:
  • Department:- Quality Control
  • Post Name: Officer / Sr. Officer / Assistant/ Technician/ Trainee
  • Qualification:   B. Sc., B.Pharm, D. Pharm, 10th , 12th, ITI (LACP, Instrumentation, AOCP )
  • Experienced: 0-7 Years experience in HPLC/ GC/ GCMS /AAS/ Dissolution/QMS.
  • Salary:NA
  • Openings:NA

Job DescriptionIpca Laboratories Limited Hiring For Officer / Sr. Officer / Assistant/ Technician/ Trainee  ! IPCA high brand equity of Domestic & International plant, manufacturing facilities from the world’s most vigilant regulatory bodies. * No entry for Interview without Covid Vaccine certificate 2nd dose

  • Important Details :
  • Location:  Athal, Silvassa, D&NH&DD
  • Post of date: 24/3/2022
  • Note:Submit your resume with subject of Department Name on Mail on hrd.athal@ipca.com 
  • Selection Process: The selection will be on the basis of Interview. 
  • Walk In Date:27th March 2022
  • Walk In Time:9: 00 to 16:00
  • Venue:HOTEL SOVEREIGN, Sea Face Road, Nani Daman, Daman (UT) – 396210. Experience of WWHO (Geneva), UK (MHRA) Exposure of Regulatory audits will be desirable

Experience of WHO (Geneva), UK (MHRA) exposure of regulatory audits will be desirable.

About Company:

We take great pleasure in introducing Episource, a leading US-based healthcare product development IT Company. Started in 2001, the company has grown multi fold in the last couple of years becoming a leader in the Medical coding space in the Heath care Domain. Episource has been rated consistently in the list of fastest-growing private establishments in the US. 

No comments:

Post a Comment